Header cover image

Australian (ASX) Pharma Industry Analysis

UpdatedJun 01, 2023
DataAggregated Company Financials
Companies36
  • 7D0.5%
  • 3M12.4%
  • 1Y-3.6%
  • YTD1.7%

Over the last 7 days, the Pharma industry has dropped 2.6%, driven by a pullback from Neuren Pharmaceuticals of 4.7%. Meanwhile, Clarity Pharmaceuticals actually outperformed within the industry, gaining 11% in the last week. However, the industry is down 5.0% over the past year. As for the next few years, earnings are expected to grow by 31% per annum.

Industry Valuation and Performance

Has the Australian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 01 Jun 2023AU$4.1bAU$993.2m-AU$640,306,659.0018.8x-6.3x4.1x
Sat, 29 Apr 2023AU$4.3bAU$993.2m-AU$641,969,868.0020.5x-6.7x4.3x
Mon, 27 Mar 2023AU$4.0bAU$995.9m-AU$648,651,745.0018.2x-6.2x4.1x
Wed, 22 Feb 2023AU$3.6bAU$981.5m-AU$594,318,566.0016.6x-6x3.6x
Fri, 20 Jan 2023AU$3.7bAU$948.3m-AU$544,428,006.0013x-6.9x3.9x
Sun, 18 Dec 2022AU$3.9bAU$948.3m-AU$544,428,006.0013.3x-7.1x4.1x
Tue, 15 Nov 2022AU$4.3bAU$948.3m-AU$544,428,005.0013.2x-7.9x4.5x
Thu, 13 Oct 2022AU$4.2bAU$882.1m-AU$556,645,005.0012.2x-7.5x4.7x
Sat, 10 Sep 2022AU$4.2bAU$943.4m-AU$537,548,829.0012.7x-7.8x4.4x
Mon, 08 Aug 2022AU$3.9bAU$819.9m-AU$339,669,589.0015.6x-11.6x4.8x
Wed, 06 Jul 2022AU$3.4bAU$818.2m-AU$353,932,589.0013.2x-9.5x4.1x
Fri, 03 Jun 2022AU$3.9bAU$818.2m-AU$353,932,589.0014.8x-11.1x4.8x
Sun, 01 May 2022AU$4.1bAU$800.9m-AU$348,637,558.0015.7x-11.7x5.1x
Tue, 29 Mar 2022AU$4.2bAU$799.2m-AU$341,805,125.0018.1x-12.4x5.3x
Thu, 24 Feb 2022AU$4.4bAU$743.6m-AU$460,156,833.0019.9x-9.6x5.9x
Sat, 22 Jan 2022AU$4.8bAU$758.4m-AU$450,516,414.0020.6x-10.6x6.3x
Mon, 20 Dec 2021AU$4.8bAU$758.4m-AU$450,516,414.0023.7x-10.5x6.3x
Wed, 17 Nov 2021AU$4.9bAU$758.4m-AU$447,307,205.0024.1x-11x6.5x
Fri, 15 Oct 2021AU$4.7bAU$753.7m-AU$446,965,453.0023.5x-10.6x6.3x
Sun, 12 Sep 2021AU$4.8bAU$753.9m-AU$445,060,581.0021.9x-10.7x6.3x
Tue, 10 Aug 2021AU$4.1bAU$752.8m-AU$442,004,016.0021.3x-9.3x5.4x
Mon, 03 May 2021AU$4.8bAU$758.7m-AU$449,177,839.0012.3x-10.6x6.3x
Thu, 04 Feb 2021AU$4.5bAU$759.6m-AU$478,696,362.0075.2x-9.5x6x
Sun, 08 Nov 2020AU$3.7bAU$761.5m-AU$402,127,165.0021.2x-9.2x4.9x
Sat, 01 Aug 2020AU$3.7bAU$773.8m-AU$314,501,632.0040.2x-11.9x4.8x
Price to Earnings Ratio

-10x


Total Market Cap: AU$4.1bTotal Earnings: -AU$405,897,729.00Total Revenue: AU$767.4mTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Pharma Industry Price to Earnings3Y Average -9.7x202120222023
Current Industry PE
  • Investors are pessimistic on the Australian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.2x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 9.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Australian Pharma compare with similar industries?

AU Market-1.60%
Healthcare0.068%
Pharma0.55%
Pharma0.55%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NEU Neuren PharmaceuticalsAU$14.152.5%
+AU$44.3m
269.5%PE9733.2x
VIT Vitura HealthAU$0.349.5%
+AU$16.7m
32.7%PE18.6x
ZLD Zelira TherapeuticsAU$2.30155.6%
+AU$15.9m
94.9%PS29.3x
MYX Mayne Pharma GroupAU$3.775.3%
+AU$15.5m
-37.2%PS0.9x
MVP Medical Developments InternationalAU$0.8213.0%
+AU$8.2m
-67.4%PS1.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ZLD

AU$2.30

Zelira Therapeutics

7D

155.6%

1Y

94.9%

MXC

AU$0.006

MGC Pharmaceuticals

7D

-14.3%

1Y

-70.0%

VIT

AU$0.34

Vitura Health

7D

9.5%

1Y

32.7%

ANP

AU$0.06

Antisense Therapeutics

7D

-4.8%

1Y

-38.1%

PXS

AU$0.055

Pharmaxis

7D

10.0%

1Y

-32.9%

MYX

AU$3.77

Mayne Pharma Group

7D

5.3%

1Y

-37.2%

NEU

AU$14.15

Neuren Pharmaceuticals

7D

2.5%

1Y

269.5%

AVE

AU$0.004

Avecho Biotechnology

7D

-20.0%

1Y

-73.3%

PBP

AU$2.57

Probiotec

7D

2.8%

1Y

11.7%

SPL

AU$0.40

Starpharma Holdings

7D

-2.4%

1Y

-43.3%

EMD

AU$0.13

Emyria

7D

8.3%

1Y

-51.9%

IHL

AU$0.10

Incannex Healthcare

7D

-4.5%

1Y

-72.0%